71 research outputs found
An Evaluation of Platelet Transfusion Response Using HLA Crossmatch-compatible Donors in Patients with Platelet Refractoriness
Background : Majority of immune-mediated platelet refractoriness is caused by HLA alloimmunization and can be effectively managed by HLA-matched platelet transfusions. However, HLA class I-typed large-sized donor registry has not been well established in Korea. We evaluated the effectiveness of platelet transfusion using HLA crossmatch-compatible donors without HLA typing. Methods : Sixteen patients showing platelet refractoriness to random donor platelets (1 hr corrected count increment [CCI] 60%) were crossmatched with 78 platelet apheresis-eligible donors using National Institute of Health (NIH) and anti-human globulin (AHG) lymphocytotoxicity methods. NIH negative/AHG negative and NIH negative/AHG positive donors were selected as best and second choice donors, respectively. Results : Eleven patients (11/16, 69%) could find NIH-crossmatch negative donors and 27 donors (27/78, 35%) belonged to the best donors. To 8 patients, 32 apheresis platelet products from 19 donors were transfused. The mean 1 hr and 24 hr CCI values from the best donors were significantly higher than those from random donors (17,893 vs 2,358, P=0.003; 8,292 vs -614, P<0.001), whereas such differences were not observed for those from the second choice donors. Platelet storage time was inversely correlated with CCI values and platelets stored :! 10 hr after collection gave significantly higher CCI values. Neither ABO match nor donor status (related vs; unrelated) affected the transfusion effectiveness. Conclusions : Effective post-transfusion platelet increment using HLA crossmatch-compatible donors was attained in patients with platelet refractoriness due to HLA antibodies, and this method can be used effectively where HLA-typed platelet donor registry is not available.
λ°°κ²½ : λ©΄μνμ μμΈμ νμνλΆμμ¦μ λλΆλΆμ HLA λμ’
λ©΄μλ°μμ μν΄ μΌκΈ°λλ©°, HLA μ ν© νμν μνλ‘ ν¨κ³Όμ μΈ νμν μ¦κ°λ₯Ό κΈ°λν μ μλ€. HLA μ ν© νμν 곡κΈμ μν΄μλ HLA class I νμνλ³κ²μ¬κ° λμ΄ μλ λκ·λͺ¨μ ννμ λ±λ‘μ λκ° νμνμ§λ§ κ΅λ΄μμλ μ΄λ° μ λκ° μ ν립λμ΄ μμ§ μλ€. λ³Έ μ°κ΅¬μμλ HLA νμνλ³κ²μ¬λ₯Ό νμ§ μκ³ HLA
κ΅μ°¨μν μ ν©ν ννμλ‘λΆν°μ νμν μνν¨κ³Όλ₯Ό νκ°νκ³ μ νμλ€.
λ°©λ² : μμνν νμνμ λν΄ νμνλΆμμ¦(1μκ° corrected count increment [CCI] 60%)μ λ³΄μΈ 16λͺ
μ νμμ λν΄ νμν μ±λΆμ±μ§μ΄ κ°λ₯ν 78λͺ
μ ννμμ μΈν¬λ
μ±κ²μ¬λ²μ μ΄μ©ν TμΈν¬ κ΅μ°¨μν(National Institute of Healthλ² λ° anti-human
globulinλ², NIHλ² λ° AHGλ²)μ μννμλ€. NIHλ² μμ±/AHGλ² μμ±μΈ κ²½μ° μ΅μ μ ννμλ‘, NIHλ² μμ±/AHGλ² μμ±μΈ κ²½μ° μ°¨μ μ ννμλ‘ μ μ νμλ€.
κ²°κ³Ό : 11λͺ
μ νμ(11/16, 69%)κ° NIH κ΅μ°¨μν μμ±μΈ ννμλ₯Ό μ°Ύμ μ μμκ³ , 27λͺ
μ ννμ(27/78, 35%)κ° μ΅μ μ ννμμ ν΄λΉνμλ€. HLA μ ν©ννμλ₯Ό μ°Ύμ μ μμλ νμ μ€ 8λͺ
μκ² 19λͺ
μ ννμλ‘λΆν° μ΄ 32νμ νμν μ±λΆμ±μ§μ μννμ¬ μννμλ€. μ΅μ μ ννμκ΅°μμλ μμνν νμν
μνμ λΉν΄ μν ν 1μκ° λ° 24μκ° CCI κ° μ μνκ² μ¦κ°νμμΌλ(17,893 vs 2,358, P =0.003; 8,292 vs -614, P<0.001), μ°¨μ μ ννμκ΅°μμλ μ΄λ¬ν μ°¨μ΄κ° κ΄μ°°λμ§ μμλ€. νμν 보κ΄μκ°κ³Ό CCI κ°μ μμκ΄κ΄κ³λ₯Ό λ³΄μ¬ μ±μ§ ν 10μκ° μ΄λ΄μ νμνμ μν μ 1μκ° λ° 24μκ° CCIκ° μ μνκ² λμ κ°μ 보μλ€. ABO μΌμΉ μ¬λΆμ νμμ ννμμ νμ°/λΉνμ° κ΄κ³ μ¬λΆλ νμν μνν¨κ³Όμ λ³λ€λ₯Έ μν₯μ 보μ΄μ§ μμλ€.
κ²°λ‘ : HLA λμ’
λ©΄μμ μν νμνλΆμμ¦ νμμμ HLA κ΅μ°¨μν μ ν© ννμλ‘λΆν° μν μ ν¨κ³Όμ μΈ νμν μμ μ¦κ°λ₯Ό 보μλ€. μ΄ λ°©λ²μ HLA μ ν© νμν ννμ λ±λ‘μ λκ° μ립λμ΄ μμ§ μμ κ²½μ°μ ν¨κ³Όμ μΌλ‘ μ΄μ©λ μ μλ€.Hod E, 2008, BRIT J HAEMATOL, V142, P348, DOI 10.1111/j.1365-2141.2008.07189.xPetz LD, 2000, TRANSFUSION, V40, P1446Kiefel V, 2001, TRANSFUSION, V41, P766WU KK, 1977, TRANSFUSION, V17, P638HERZIG RH, 1977, TRANSFUSION, V17, P657KLINGEMANN HG, 1987, BRIT J HAEMATOL, V66, P115HEAL JM, 1987, BLOOD, V70, P23BOLGIANO DC, 1989, TRANSFUSION, V29, P306MOROFF G, 1992, TRANSFUSION, V32, P6331997, N ENGL J MED, V337, P1861Legler TJ, 1997, ANN HEMATOL, V74, P185Sacher RA, 2003, ARCH PATHOL LAB MED, V127, P409MCFARLAND JG, 2003, APHERESIS PRINCIPLES, P199Datema G, 2000, VOX SANG, V79, P108PARK MH, 1999, KOREAN J BLOOD TRANS, V10, P203Davis KB, 1999, TRANSFUSION, V39, P586PARK HD, 2004, KOREAN J LAB MED, V24, P426Vassallo RR, 2007, CURR OPIN HEMATOL, V14, P655
Electrodiagnostic Study of bulbocavernosus reflex
μνκ³Ό/μμ¬[μλ¬Έ]
[νκΈ]
λ°°λ¨ μ€μΆ(micturition center)μ λ°κΈ°μ κ΄λ ¨λλ μ± λ°μ¬(sexual reflex) μ€μΆλ λͺ¨
λ μ 2-4 μ²μμ μμΉνκΈ° λλ¬Έμ λ°°λ¨ μ₯μ λ μ±κΈ°λ₯ μ₯μ νμμ μμ΄μ ꡬν΄λ©΄μ²΄λ°μ¬(b
ulbocavernosus reflex)μ κ²μ¬λ μμμ μΌλ‘ λ§€μ° μ€μνλ€.
κ·Έλ¬λ μμμ μΈ κ²μ¬λ§μΌλ‘λ λ°μμ μ 무λ§μ μ μ μμΌλ©° λ°μμ΄ νμ€νμ§ μμ κ²½
μ°λ μκ³ κ°νΉ κ°μμ±(false negative)λ°μμ 보μ΄κΈ°λ νλ©° λΆλΆμ μΈ μ κ²½μμμ΄ μλ
κ²½μ°μλ κ·Έ μ λλ₯Ό μΈ‘μ ν μκ° μμ΄ μ νν νκ°κ° μ΄λ €μ λ€.
λ³Έ μ°κ΅¬μμλ μ κΈ°μ§λ¨νμ λ°©λ²μ μ΄μ©νμ¬ κ΅¬ν΄λ©΄μ²΄λ°μ¬μ μ 볡μκ°μ μΈ‘μ ν¨μΌλ‘μ¨
κ·Έ μ§λ¨μ κ°μΉ λ° μμμ κΈ°μ¬λλ₯Ό μμλ³΄κ³ μ νμλ€.
1984λ
6μλΆν° 1986λ
1μκΉμ§ μ°μΈλνκ΅ μκ³ΌλνλΆμ μΈλΈλμ€λ³μ μ¬νμνκ³Ό κ·Ό
μ λ κ²μ¬μ€μμ μ μ μ±μΈ 13λͺ
μ λμμΌλ‘ ꡬν΄λ©΄μ²΄λ°μ¬μ μ 볡μκ°μ μΈ‘μ νμ¬ κ·Έ ν
μ€μΉλ₯Ό ꡬνκ³ μ±κΈ°λ₯ μ₯μ μμ μ²μμμ νμ 119λͺ
μ λμμΌλ‘ ꡬν΄λ©΄μ²΄λ°μ¬μ μ 볡μ
κ°μ μΈ‘μ νμ¬ λ€μκ³Ό κ°μ κ²°κ³Όλ₯Ό μ»μλ€.
1. μ μ μ±μΈμ ꡬν΄λ©΄μ²΄λ°μ¬μ μ 볡μκ° νμ€μΉλ 33.9Β±3.04msecμ΄μμΌλ©° (μ μ λ²μ
27.9-40.Omsec) μ’μ°μΈ‘μ μ 볡μκ° μ¬μ΄μλ ν΅κ³νμ μΌλ‘ μ μν μ°¨μ΄κ° μμλ€(p>0.05
).
2 .κΈ°λ₯μ μΈ μ±κΈ°λ₯ μ₯μ μμ μ²μ μλΆμ μ²μμμ νμμμλ μ 볡μκ°μ νκ· μΉκ°
κ°κ° 34.6Β±3.45msecμ 34.6Β±3.44msecλ‘μ μμΈμ νμ€μΉμ μ μν μ°¨μ΄κ° μμλ€(p>7.05
).
3. μ±κΈ°λ₯ μ₯μ λ₯Ό νΈμν λΉλ¨λ³ νμμ 46.2%μμ μ 볡μκ°μ΄ λΉμ μμΌλ‘ λνλ¬μΌλ©°
μ΄λ€μμλ λΉλ¨λ³μ± μ κ²½λ³λ³μ΄ μ±κΈ°λ₯μ₯μ μ μ£ΌμμΈμ΄λΌκ³ μκ°ν μ μμκ³ , μ 볡μκ°
μ νκ· μΉ(41.1Β±7.20msec)λ νμ€μΉμ μ μν μ°¨μ΄κ° μμλ€(P<0.01).
4 .μ±κΈ°λ₯ μ₯μ λ₯Ό νΈμν κ³¨λ° λ° νμλΆμμ νμμ 36.0%μμ μ 볡μκ°μ΄ λΉμ μμΉλ₯Ό
보μμΌλ©° λ§μ΄μ κ²½μ μμμ΄ μμμ μ§λ¨ν μ μμλ€.
5. μ²μμμΆ λ° λ§λ―Έμμ νμμμλ μ κΈ°μ§λ¨νμ μΈ κ²μ¬λ°©λ²μΌλ‘ μ±κΈ°λ₯ μ₯μ μ μ κ²½
μΈμ± λ°©κ΄μ μ νμ ꡬλΆνκ±°λ μμμ μ λλ₯Ό μΈ‘μ νλ λ°μ λμμ μ€ μ μμλ€.
Electrodiagnostic Study of Bulbocavernosus Reflex
Myoung Hee Park
Department of Medical Science The Graduate School, Yonsei University
(Directed by Assistant Prof. Chang Il Park, M.D.)
Clinical evaluation of the bulbocavernosus reflex is very Important in patients
with voiding difficulty and sexual dysfunction because the physiologic micturition
center is located in the S2-S4 spinal cord level which is also associated with the
mechanism of sexual reflex, especially of erection.
However, accurate assessment was difftcult because: (1) with clinical examination
alone, only the presence of reaction could be assessed (2) reaction may not be
definite (3) often false negative reaotions appeared, and (4) degree of injury
could not be assessed in cases with partial nerve inJury.
The obtectives of this study were to demonstrate the diagnostic value and the
clinical usefulness of the electrodiagnostlc test in measurement of latency time of
the bulbocavernosus reflex.
Thirteen normal adult males served as controls for this study. 119 pations with
sexual dysfunction and spinal cord injury who were referred to the EMG laboratory
of Rehabilitation Medicine Department, Severance Hospital, Yonsei University, were
studied from June 1984 to January 1986.
The results are as follows :
1. The latency time of the bulbocavernosus reflex in normal subjects was
33.9Β±3.04 msec (normal range : 27.9-40.0 msec) and there was no significant
difference between right and left sides(P>0.05).
2. The mean bulbocavernosus reflex latency time in cases of functional sexual
dysfunction and suprasacral spinal cord injury was not significantly different
compared with normal mean values(P<0.01).
3. 46.2% of diabetic patients with sexual dysfunction skowed abnormailty in
latency time and the main cause of sexual dysfunction in thls group might be due to
diabetic neuropathy. The mean in latency time of the diabetic group showed a
significant difference(P<0.01).
4. 36.0% of patients with pelvic and perineal area injury and sexual dysfunction
showed an abnormality in latency time and could be diagnosed to have peripheral
nerve injury.
5. Electrodliagnostic study in the patients with conus medullaris and/or cauda
eaulna lesion was useful in classifying the types of sexual dysfunction and
neurogenic bladder and the degree of injury.restrictio
Effect of Retinly Palmitate on the Hepatic Fibrosis Induced by Prolonged Administration of Carbon Terachloride
μνκ³Ό/λ°μ¬[νκΈ]
κ°μμ½μ μ¬μ νμ μμ΄μ κ΅μμ¬μ μ μΈν¬νμ κΈ°μμΌλ‘λ ItoμΈν¬μ κ°μΈν¬κ° κ±°λ‘ λκ³ μλ€. κ·Έ μ€ ItoμΈν¬λ κ°μ₯λ΄ λΉνλ―Ό Aμ μ μ₯κ³Ό κ΅μμ¬μ ν©μ± λ± μ μ΄λ 2κ°μ§μ κΈ°λ₯μ κ°μ§κ³ μλ€κ³ μκ°νκ³ μλ€. κ·Έλ¬λ―λ‘ μ€νλλ¬Όμ λΉνλ―Ό Aλ₯Ό ν¬μ¬νλ©΄ ItoμΈν¬μ μλ©΄κΈ°λ₯ μ€κ΅μμ¬μ ν©μ± κΈ°λ₯μ΄ μ΅μ λ κ°λ₯μ±μ΄ μλ€. λ°λΌμ μ£Όλ‘ κ°μμ½ μμμ μ΄λνλ μ¬μΌννμλ₯Ό λ°λ³΅ ν¬μ¬νμ¬ κ°μμ½ μ¬μ νλ₯Ό μΌμΌν€κ³ , λΉνλ―Ό Aμ λ³νν¬μ¬κ° μ΄μ λ―ΈμΉλ μν₯μ ꡬλͺ
νκ³ μ λ³Έ μ°κ΅¬λ₯Ό μννμλ€.
μ€νμλ μ«μ»· ν°μ₯ 200λ§λ¦¬λ₯Ό λμ‘°κ΅°(μ μλμ‘°κ΅° λ° salad oilλ¨λ
ν¬μ¬κ΅°), λΉνλ―Ό A λ¨λ
ν¬μ¬κ΅°, μ¬μΌννμλ¨λ
ν¬μ¬κ΅°, μ¬μΌννμμ λΉνλ―Ό A λ³νν¬μ¬κ΅°μΌλ‘ λλμ΄ μ¬μ©νμλ€. μ¬μΌννμλ₯Ό μ₯κΈ°κ° λ°λ³΅ν¬μ¬νκΈ° μνμ¬ μλΉμ€νμΌλ‘λΆν° 첫ν ν¬μ¬λμ μ νκ³ , κ·ΈνλΆν°λ λ§€μΌ λλ¬Όμ 체μ€μ μΈ‘μ νλ©΄μ ν¬μ¬λμ μ¦κ°νμ¬ 1μ£Όλ§λ€ νλ²μ© 1βΌ15ν 경ꡬν¬μ¬νμλ€. λΉνλ―Ό Aν¬μ¬κ΅°μλ retinyl palmitate 5Γ10**4 IU/ratλ₯Ό μ¬μΌννμ 첫ν ν¬μ¬ 1μ£ΌμΌ μ λΆν° 4μ£Όκ°κ²©μΌλ‘ νΌνμ£Όμ¬νμλ€. μ¬μΌννμμ μν κ° μμμ μ΄μ§μν€κΈ° μνμ¬ μ¬μΌννμ 첫ν ν¬μ¬ 3μΌμ λΆν° 3νμ κ±Έμ³ 15mg/dayμ sodium phenobarbitalμ 볡κ°λ΄ μ£Όμ¬νμλ€. λμ‘°κ΅°κ³ΌλΉνλ―Ό A λ¨λ
ν¬μ¬κ΅°μ 맀 4μ£Όλ§λ€, μ¬μΌννμλ¨λ
λ° λΉνλ―Ό A λ³νν¬μ¬κ΅°μ 맀 2μ£Όλ§λ€ 5λ§λ¦¬μ© λμ΄νμ¬ νμ² GPT, κ°μ₯μ 무κ², κ°μ‘°μ§λ΄ μκ°νκ΄μΈν¬μ μ, κΈμ± κ° μμμ λ, κ°μ¬μ νκ³Όμ λ° μ λ, κ°μΈν¬ λ° ItoμΈν¬ λ΄μΈμ λ―ΈμΈκ΅¬μ‘°λ³νλ₯Ό κ΄μ°°ν λ° λ€μκ³Ό κ°μ κ²°κ³Όλ₯Ό μ»μλ€.
1. μ¬μΌννμ λ¨λ
λ° λΉνλ―Ό A λ³νν¬μ¬λ νμ² GPTμΉλ₯Ό μμΉμν€κ³ κ°λ¬΄κ²λ₯Ό μ¦κ°μν€λ©°, μ΄λ λΉνλ―Ό A λ³νν¬μ¬μμ λ μ¬νμκ³ μ¬μΌννμ λ¨λ
ν¬μ¬κ΅°μμλ λ¨κΈ°κ° ν¬μ¬ν κ²½μ°μλ§ λλ ·νμλ€.
2. μ¬μΌννμ λ¨λ
λ° λΉνλ―Ό A λ³νν¬μ¬λ κ°μμ½λ΄, μ£Όλ‘ λ§λ¨κ°μΈμ λ§₯μ£Όλ³μ μκ°νκ΄μΈν¬μλ₯Ό νμ νκ² μ¦κ°μμΌ°μΌλ©°, μ΄λ νΉν λΉνλ―Ό A λ³νν¬μ¬κ΅°μμ λ μ¬νμλ€.
3. μ¬μΌννμ λ¨λ
λ° λΉνλ―Ό A λ³νν¬μ¬λ κ°μΈν¬ μ’
μ°½, μ΄μ κ΄΄μ¬, λ§λ¨κ°μΈμ λ§₯μ£Όλ³κ΄΄μ¬λ±μ κΈμ± κ°μμ½λ³νλ₯Ό μ΄λνμμΌλ©°, μ΄λ¬ν λ³νλ€μ μ¬μΌννμ λ¨λ
ν¬μ¬λ³΄λ€ λΉνλ―Ό A λ³νν¬μ¬μ μ’λ μ¬νκ³ λ¦κ²κΉμ§ κ΄μ°°λμλ€.
4. μ¬μΌννμ λ¨λ
λ° λΉνλ―Ό A λ³νν¬μ¬λ λ§λ¨κ°μΈμ λ§₯μ£Όλ³μμλΆν° μμνμ¬ μΈμ λ§λ¨κ°μΈμ λ§₯ λ° λ¬Έλ§₯μκ³Ό μ°κ²°λλ μΌλ ¨μ μ¬μ νλ₯ μ΄λνλ©°, μ΄λ¬ν μ¬μ νλ μ¬μΌννμ λ¨λ
ν¬μ¬μμ λ³΄λ€ μ¬νκ³ λΉ¨λ¦¬ μ§νλμλ€.
5. μ¬μΌννμλ₯Ό λ¨λ
λλ λΉνλ―Ό Aν λ³ννμ¬ 5νμ΄μ ν¬μ¬ν κ²½μ°μλ κ°μΈν¬λ΄μμ κ΅μμ¬μ κ° λ°κ²¬λμμΌλ©°, μ΄λ¬ν μ견μ μ¬μΌννμ λ¨λ
ν¬μ¬μμ λ μμ£Ό κ΄μ°°λμλ€. λν μ¬μΌννμ λ¨λ
ν¬μ¬λ ItoμΈν¬λ‘λΆν° μ΄νν ItoμΈν¬λ‘μ λ³νμ μ΄μ§νμλ€.
μ΄μμ κ²°κ³Όλ₯Ό μ’
ν©νλ©΄ μ¬μΌννμ λ°λ³΅ ν¬μ¬λ κ°μ€μ§μ μμμ κ±°μ³ μΌλ ¨μ μ¬μ νλ₯Ό μ λ°νλλ° μ΄λ¬ν μ¬μ μ‘°μ§μ μ΄νν ItoμΈν¬μ κ°μΈν¬μμ ν©μ±λλ©°, λΉνλ―Ό A λ³νν¬μ¬λ μ¬μΌννμ λ¨λ
ν¬μ¬μ μν κΈμ± κ°μμμ μ¦κ°μν€λ λ°λ©΄ μ΄νν ItoμΈν¬λ‘μ
λ³νμ¨ μ΅μ νμ¬ μ¬μΌννμμ μν μ¬μ μ‘°μ§ν©μ±μ μ§μ° λλ κ°μμν€λ κ²μΌλ‘ μ¬λ£λλ€.
[μλ¬Έ]
The cellular origin of hepatic intralobular fibrosis is not completely known. Although there are reports indicating that hepatocyte itself synthesizes collagen fibers, it is widely accepted that Ito cell Participates in collagen formation. It?
cells contain most of hepatic vitamin A in their abundant lipid droplets, and recent studies have suggested that the administration of vitamin A mar allow Ito cells to devote themselves in storing the vitamin A, which in turn inhibits
transformation of the Ito cells to collagen forming cells. The present study is undertaken to determine the effect of vitamin A on the development of fibrosis induced by repeated administration of CCI^^4
Two hundred male albino rats, weighing about 190 gm, were divided into control groups(normal and given salad oil alone) and experimental groups(treated with vitamin A, CCI^^4,arid CCI^^4 plus vitamin A),
The maximal nonlethal dose of CCI^^4 was determined in a preliminary experiment. The initial oral dope of CCI^^4 administration was followed by 2 to 15 subsequent weekly dosers of CCI^^4 which were modified according to the changes in body
weights. Retinyl palmitate(5Γ10**4 IU/rat) was administered subcutaneously once every 4 weeks to the experimental animals to be given vitamin A. Beginning 3 days prior to the initial dose of CCI^^4, rats were given sodium phenobarbital(15 mg/rat/day) by intraperitoneal injection for induction of the microsomal enzyme and to facilitate the CCI^^4 induced liver injury.
Five animals were killed every 4 weeks for the control and vitamin A alone groups, and every 2 weeks for the CCI^^4 alone and CCI^^4 plus vitamin A groups.
The changes of serum GPT activity, liver weights, and the numbers of autofluorescent cells within hepatic lobule were determined. Also, the microscopical changes of acute liver injury and hepatic fibrosis, and the ultrastructural changes in and about the liver parenchymal and Ito cells were determined.
The results were summarized as follows :
1. Administrations of CCI^^4 plus vitamin A Produced increases of serum GPT levels and relative liver weights throughout the experiment. These increases were also induced by administering CCI^^4 alone, but were distinct only following the first few administrations.
2. Repeated Administrations of CCI^^4 alone or in combination with vitamin A led to a marked increase in the numbers of hepatic autofluorescent cells, moat of which were found in perivenular areas. The increase was more severe in animals given the combination of CCI^^4 and vitamin A, particularly in the lest half of the experimental duration.
3. Administration of CCI^^4 alone or in combination with vitamin A led to acute changes of the liver, such as liver cell swelling, focal hepatocytolysis and perivenular necrosis. These changes were more or less severe and long-tasting in the animals given CCI^^4 plus vitamin A.
4. Administration of CCI^^4 alone or in combination with vitamin A gave rise to hepatic fibrosis. The fibrosis began initially around THV, gradually extending to join with the nearby perivenular fibrosis and then with portal tracts, and eventually to form complete septa. This progression of hepatic fibrosis appeared t? be more rapid and severe in animals treated with CCI^^4 alone.
5. In animals treated 5 times or more with CCI^^4, there were several hepatocytes containing collagen fibers within their cytoplasm. These hepatocellular collagen seemed less frequent in animals given CCI^^4 plus vitamin A. Transformed Ito cells
were also more frequent in animals treated with CCI^^4 alone than those treated with CCI^^4 pius vitamin A.
In conclusion, repeated administrations of CCI^^4 cause an acute liver injury, which is followed by consecutive collagenous fibrosis Within the hepatic lobules, and the transformed Ito cello as well as the liver calls are considered to be responsible for the collagen formation. Treatment with vitamin A aggrevates the CCI^^4 induced acute liter injury and yet, inhibits or delays the progression of hepatic fibrosis by interfering the transformation of Ito cells to collagen producing cells.restrictio
κ³ νμ’ μμ μμ λ° λ³λ¦¬μ‘°μ§νμ μ°κ΅¬
μνκ³Ό/μμ¬[μλ¬Έ]
[νκΈ]
κ³ νμ’
μμ ν¬κ·νμ§λ§ λΉκ΅μ μ μ μ°λ Ήμ νΈλ°νκ³ λ€μν μ‘°μ§νμ μμκ³Ό μμμ
νΉμ§μ λνλ΄λ©°, λλΆλΆμ μ
μ±μ’
μμ΄λ€. μ°λ¦¬λλΌμμλ κ³ νμ’
μμ λν μ°κ΅¬κ° λΉκ΅
μ μ μΌλ―λ‘ λ³Έ μ°κ΅¬λ₯Ό μμνμλ€.
μ°κ΅¬μ¬λ£ λ° λ°©λ²
μ°κ΅¬μ¬λ£λ‘λ 1959λ
7μ 1μΌλΆν° 1979λ
6μ 30μΌκΉμ§ 20λ
κ° μ°μΈλνκ΅μ μ΄νμ¬μ
λνκ΅ μκ³Όλν, 1968λ
7μ 1μΌλΆν° 1979λ
6μ 30μΌκΉμ§ 11λ
κ° κ³ λ €λ³μ λ° 1974λ
7
μ 1μΌλΆν° 1979λ
6μ 30μΌκΉμ§ 5λ
κ° λ°±λ³μμμ κ²μλ μ΄ 68μμ κ³ νμ’
μμ λμμΌ
λ‘ νμλ€. μμκΈ°λ‘μ μ°Έκ³ ν μ μμλ 34μμ λν΄μλ κΈ°λ‘μ μ‘°μ¬λΆμ νμμΌλ©° λ³
리쑰μ§νμ κ²μμ 10%μ€μ± ν¬λ₯΄λ§λ¦°μ κ³ μ ν ν νλΌνμ ν¬λ§€νκ³ 6ΞΌμ λκ»λ‘ μΈμ
νμ¬ hematoxylin-eosinμΌμν νλ―Έκ²½μ κ²μμ νμλ€.
μ°κ΅¬κ²°κ³Ό
1. μ‘°μ§νμ λΆλ₯μ λΉλμ μμ΄μλ νμμμ΄ 17μ(25%)λ‘ κ°μ₯ λ§μκ³ μ μνΌμ’
μ΄ 15
μ, κΈ°νμ’
μ΄ 12μ, λν©λμ’
, νΌν©ν μμμΈν¬μ’
μ, μ
μ±μνμ’
μ΄ κ°κ° 7μμ©μ΄μκ³ ν‘
λ¬Έκ·Όμ‘μ’
μ΄ 2μ, μμμ μμΈν¬μ’
μ΄ 1μμλ€.
μ‘°μ§νμ μ견μ μΈλΆν΄ 보면 μ μνΌμ’
15μμ€ μ μνμ΄ 13μ, μνμ±νμ΄ 2μμμΌλ©°,
κ°μ§μ‘°μ§μ μ¬μ νμ μνꡬ μΉ¨μ€μ λλ μ€λ±λ μ΄μμ΄ κ°κ° 8μ(54%) λ° 9μ(60%)μλ€.
κ°μ§μΈν¬ μ¦μ μ 무λ₯Ό κ΄μ°°ν μ μμλ 13μμ€ 6μμμ κ°μ§μΈν¬ μ¦μμ 보μλ€.
2. μ 체 κ³ νμ’
μμ νκ· μ°λ Ήμ 22μΈμμΌλ©° μ μνΌμ’
μ΄ 35.6μΈ, νμμμ΄ 15.4μΈ. λν©
λμ’
μ΄ 2.4μΈ, κΈ°νμ’
μ΄ 12.7μΈ, μ
μ±μνμ’
μ΄ 42.7μΈμκ³ μ°λ Ήλ³ λΉλλ 5μΈ μ΄νμ 20
βΌ39μΈμμ λμ λΉλλ₯Ό 보μ¬μ£Όμλ€.
3. μ£Ό μμμ¦μμ λν΅μ μλ°νμ§ μμ μλλ΄ μ’
κ΄΄μ΄μ§κ° 38%λ‘ κ°μ₯ λ§μκ³ , λ€μμ΄
λν΅μ μλ°ν μλλ΄ μ’
κ΄΄μ΄μ§, λ³΅λΆ μ’
κ΄΄μ΄μ§ λ±μ μμμμΌλ©° λ΄μμ κΉμ§μ λ³λ ₯κΈ°
κ°μ 6κ°μ λ―Έλ§μ΄ 36.4%λ‘ κ°μ₯ λ§μκ³ 2λ
μ΄μμ κΈ΄ λ³λ ₯κΈ°κ°μ κ°μ§ κ²½μ°λ 21.2%λ
λμλ€.
4. κ³ νμ’
μμ λ°μλΆμλ₯Ό 보면 μμΉλ₯Ό μ μ μμλ 57μ μ€ μλλ΄κ° 50μλ‘ 88%μκ³
볡λΆκ° 6μ, μν΄λΆκ° 1μμμΌλ©°, μ’μ° λ°μλΉλλ κ°μλ€. μμΈ‘μ±μΌλ‘ λ°μλ κ²½μ°κ° 4
μμκ³ μ΄μ€ 2μμμλ μμΈ‘μ΄ κ°κ° λ€λ₯Έ μ‘°μ§νμ μμμ 보μ¬μ£Όμλ€.
5. μΉλ£λ°©λ²μ μ μ μμλ 33μ μ€ κ³ νμ μ μ λ§ μνν κ²½μ°κ° 24μ(73%)λ‘ κ°μ₯ λ§
μλ€.
Clinico-Pathological Studies on Testicular tumors among Koreans
Hyoung Hee Park
Department of Medical Science, The Graduate School, Yonsei University
(Directed by Yoo Bock Lee, M.D., D.M.Sc.)
Tumor of the testis comprises only a small percentage of all human malignancy,
but they unfortunately strike with greatest frequency young and productive men. No
other organ, except the ovary, manifests the broad spectrum of clinical behavior or
the wide structural range of neoplasia as that encountered in the testis.
There has been very little comprehensive study on testicular tumors among
Koreans. The present study is, therefore, intended to establish a basic studies of
testicular tumors among Koreans from clinical and pathological aspects.
Materials and Method
Sixty-eight cases of testicular tumors were examined in the Department of
Pathology, Medial College, Yonsei University and Ewha Women's University from July
1, 1959 to June 30, 1979, Korean General Hospital from July 1, 1968 to June 30,
1979 and PAIK. Hospital from July 1, 1974 to June 30, 1979.
All Specimen were surgically excised on the assumption that they were testicular
neoplasms.
The histologic observations were made on hematoxylin and eosin stained sections
available for all cases.
For 34 cases of the testicular tumor whose clinical records were available, age,
sex, location, chief complatints and symptom duration were investigated.
Result and Summary
Based on clinical and histopathological studies of 68 cases of testicular tumor,
following results were obtained.
1. Of 68 cases, seminoma was 15(22.1%) cases, embryonal carcinoma was 17(25%)
cases, teratoma was 12(17%) cases, yolk sac tumor, combined type of germ cell
tumor, and malignant lymphoma were 7(10.3%) cases, respectively, rhabdomyosarcoma
was 2 cases and gonadoblastoma was 1 case.
Among 15 cases of seminoma, 13 were classical seminoma and 2 were anaplastic
seminoma. Of 12 cases of teratoma, 9 were mature teratoma and 3 were immature
teratoma.
2. The most frequent chief complaint was palpable scrotal mass without pain which
were present in 13 cases out of 34 cases whose clinical records were available. In
35% of these 34 cases symptoms were present for less than 6 months, and in 21%
symptoms were present for over 2 years.
3. The tumor incidence was equal for each testis.
Among 57 cases whose records were available, 4 cases had bilateral lesions and 6
cases occured in undescended testes.
4. The mean age of total 68 testicular tumors was 22 years, and 35.6 years in
seminoma, 15.4 years in embryonal carcinoma, 2.4 years in yolk sac tumor, 12.7
years in teratoma, and 42.7 years in malignant lymphoma. The most frequent age
group was the first decade.
5. among 33 cases whose records were available, 24 cases(73%) received
orchidectomy only.restrictio
(The) analysis has concluded that the 5-day stop smoking program has favorably influenced adolescents to quit smoking
μν λ° κ±΄κ°μ¦μ§νκ³Ό/μμ¬[νκΈ]
λ³Έ μ°κ΅¬λ μ²μλ
5μΌκΈμ°νλ‘κ·Έλ¨ μ€μ 6κ°μ νμ κΈμ°μ¨κ³Ό κΈμ° μ€ν¨μμΈμ λΆμνμ¬ ν₯ν μ²μλ
κΈμ°νλ‘κ·Έλ¨μ λ°©ν₯μ μ μνκ³ μ μ€μνμλ€. 2002λ
3μλΆν° 12μκΉμ§ μμΈμμλ³μλΆμ€ 5μΌκΈμ°νκ΅μμ κ΅μ‘μ λ°μ κ³ λ±νμμ λμμΌλ‘, 2003λ
6μ κ° νκ΅λ₯Ό λ°©λ¬Ένμ¬ 94λͺ
μκ² μ€λ¬Έμ λ°μλ€.
μμ§λ μλ£λΆμμ SAS ν΅κ³νλ‘κ·Έλ¨μ μ΄μ©νμλ€. μΌλ°μ νΉμ±μ μ€μμ λ°±λΆμ¨λ‘, κΈμ° μ±κ³΅μμ μ€ν¨μμ νΉμ± λΉκ΅λ t-testμ X2-test κ·Έλ¦¬κ³ ANOVAλΆμμΌλ‘, λμμμ νΉμ±κ³Ό κΈμ°κΈ°κ°μ λΉκ΅λ life-testλ₯Ό μ΄μ©ν Log-Rank λ°©λ²μΌλ‘, κΈμ° μ€ν¨μ κ°μ₯ ν° μν₯μ λ―ΈμΉλ μμΈ λΆμμ Cox''s λΉλ‘μν νκ·λΆμμ μ΄μ©νμλ€.
λ³Έ μ°κ΅¬μ κ²°κ³Όλ λ€μκ³Ό κ°λ€.
1) μ²μλ
κΈμ°νλ‘κ·Έλ¨ μ€μ 6κ°μ νμ κΈμ° μ±κ³΅λ₯ μ 55.32%μ΄μλ€. κΈμ° μ±κ³΅μμ 65%κ° κΈμ°νλ‘κ·Έλ¨μ μν₯μ λ°μ κ²μΌλ‘ μ‘°μ¬λμκ³ , κ°μ₯ λμμ΄ λμλ νλ‘κ·Έλ¨μ κΈμ°μνμ μλ£κ°μμλ€.
2) κΈμ° μ±κ³΅μμ νΉμ±μ μ΄ν΄λ³΄λ©΄ λ¨νμμ 43.86%, μ¬νμμ 72.97%κ° κΈμ°μ μ±κ³΅νκ³ μμλ€. κΈμ° μ±κ³΅μμκ² μμ΄μ κΈμ°μ μ μ§νκΈ° νλ€μλ μ΄μ λ μ€νΈλ μ€ λ°μ λ(38.46%)μ μ΅κ΄μ±(36.54%)λλ¬Έμ΄λΌκ³ νμμΌλ, 건κ°μ λν μκ°(44.23%)κ³Ό κ°ν μμ§(32.69%)λ‘ κΈμ°μ μ μ§ν μ μμλ€κ³ νλ€. κΈμ°μ νλ©΄μ μ’μμ§ κ²μ μ©λμ΄ μ μ½(34.62%) λκ³ μ΄λ μ μ¨μ΄ μ°¨μ§ μλ κ²(23.08%)μ΄μλ€.
3) κΈμ° μ€ν¨μμ νΉμ±μ μ΄Β·μ€νκ΅ λ 첫 ν‘μ°μ μμν νμμ 51.23%κ° κΈμ°μ μ€ν¨νκ³ μμλ€. κΈμ°μ μ€ν¨ν μ΄μ λ λ΄λ°°μ λν μ΅κ΄μ±(50.00%)κ³Ό μμ§λΆμ‘±(16.67%) λλ¬Έμ΄μκ³ , μ€ν¨μμ 95.24%κ° μμΌλ‘ κΈμ° ν κ³νμ κ°κ³ μμλ€.
4) κΈμ° μ€ν¨μ μν₯μ λ―ΈμΉλ μμΈμ μ’
ν© λΆμν΄ λ³Έ κ²°κ³Ό, κ°μ₯ μ μνκ² λμ¨ λ³μλ 첫 ν‘μ° μμμκΈ°μλ€. μ΄Β·μ€νκ΅ λ ν‘μ°μ μμν κ²½μ°μ λΉν΄ κ³ λ±νκ΅ λ ν‘μ°μ μμν κ²½μ° κΈμ°μ μ€ν¨ν νλ₯ μ΄ 0.13λ°°λ‘ λνλ¬λ€.
μ΄μμ μ°κ΅¬κ²°κ³Όλ₯Ό μ’
ν©ν΄ 보면, κΈμ° μ±κ³΅μμ 65%κ° κΈμ°νλ‘κ·Έλ¨μ μν₯μ λ°μ κ²μ λ³Ό λ, μ²μλ
κΈμ°νλ‘κ·Έλ¨μ νμ€ν ν¨κ³Όκ° μμλ€. κ·Έλ¬λ μ²μλ
κΈμ° μ€ν¨μ κ°μ₯ μν₯μ λ―ΈμΉλ μμΈμ΄ 첫 ν‘μ° μμμκΈ°μΈ κ²μ κ°μνλ€λ©΄, μ μΉμμκ³Ό μ΄λ±νμ λμμΌλ‘ ν‘μ°μλ°© νλ‘κ·Έλ¨μ κ°λ°νμ¬ μ€μνλ€λ©΄ λμ± ν° ν¨κ³Όκ° μμ κ²μ΄λ€.
[μλ¬Έ]This study was performed on adolescents 6 months after completing the stop smoking program. The purpose of this study was to investigate the percentage who had stopped and other factors that influenced them. All 94 students were selected for this study. The whole population was investigated by questionnaire. The data analysis is used for SAS statistics program with X2-test, T-test, ANOVA, life test and Cox''s proportional hazard regression analysis.
The results are as follows:
1) The stop smoking rate was 55.32% after completing the stop smoking program. 68% of them were influenced by the stop smoking program. The participants especially enjoyed stop smoking movies and medical lectures.
2) 43.86% of male students and 72.97% of female students succeeded in breaking the habit of smoking. The main reason for their overcoming the smoking habit was that they possessed strong will-power and they strongly desired good health. As they stopped smoking, they were able to save their pocket money and comfortably breathe.
3) The main reason some participants failed was lack of will-power. Most of them started smoking in elementary school or middle school. 51.3% of them failed because of their addiction to tobacco and their lack of will-power to stop. But 95.24% of them have a plan to quit smoking in the future.
4) Their first smoking experience was found to have a very significant influence on the possibility of success in stopping the habit quit smoking. Adolescents who started in elementary or middle school were less likely to successfully stop smoking than those who started in high school.
In conclusion, all the study revealed that a long effective period of smoking cessation can''t be generalized. Because the students in this study were chosen with some limitations. But the rate of the successful overcomers is relatively high with 55.32%. Therefore we surely must develop the most effective smoking cessation programs possible. It is very important to teach kindergarten and elementary school students to avoid tobacco because of its bad effects on health.ope
Studies on the Distribution of HLA Antigens in Normal Koreans
The distribution pattcrn of HLA-A,B,C antigens
was investigated in 105 normal healthy unrelated
Korean adults. The HLA-A, B, C typing was carried
out by the standard NIH technique , using trays
obtained from UCLA Tissue Typing Laboratory. Gene
frequencies were estimated from antigen frequencies
using the formula GF=I γI f-δΊAI' and haplotype
frequencies and gametic associations between HLAAlB
and HLA-B/C loci were calculated according to
Mattiuz et a1
The data were analyzed and summarized as follows
l. In normal Korean population, most frequent
antigens for the HLA-A locus were A2 51. 4%,
Aw24 49.5% , Aw33 23.8% and All 15.2% and
for the HLA-B locus Bw51 22.9%, Bw62 21. 0%,
Bw44 18.1%, Bw61 13.3% and Bw54 13.3% and
for the HLA-C locus Cw3 49.5%, Cwl 37.1%
and Cw4 I I. 4% in decreasing order of frequency.
Antigens of very low frequeneies C1%~2%) were
AI. Aw23, A29, Aw34, B8, B37, Bw38 and
Bw63. HLA-A25, A28, Aw32, BI4, BI8, Bw41,
Bw42, Bw45, Bw46, Bw47, Bw49, Bw50,
Bw53. Bw56 and Bw57 antigens were absent.
Blank gene frequencies were rather low; HLA-A
locus 1. 7%, HLA-B locus 5.3%, HLC-C locus
42.8%.
2. These HLA antigen frequencies of the Korean
population were quite similar to the Japanese
population, but in the Korean population, frequeneies
of A3, Aw30, Aw33, BI3, B27 and Bw
58 were higher and those of A26 and Bw52 were
lower compared to the Japanese population.
3. The common haplotypes(per 10,000) in the Korean
population were A2 Bw5!(647) , Aw33 Bw44(616) ,
Bw54 Cw!(690) and Bw58 CγοΌ3(589). Significant
positive gametic associations were noted for eight
haplotypes(p<O. 05); Aw24 Bw52, Aw31 Bw51,
Aw33 Bw44, Aw33 Bw58, Bw54 Cwl, BX Cwl,
Bw58 Cw3 and Bw62 Cw4.
4. Although some differences were noted , the haplotype
frequencies and the patterns of gametic
associations in the Korean population were more
or less similar to those of the Japanese population.
Further studies are needed to confirm the genetic
similarities and differences for the HLA antigen
system between these two ethnic population
Blood coagulation studies in patients with cancer
A study of hemostatic abnormalities in 102 randomly
selected cancer patients was undertaken t()
evaluate the overall incidence and types of bemostatic
derangements in these patients by 15 coagulation
tests.
The results are as follows:
L Majority of the patients showed one or more
abnormal coagulation tests and two thirds had four
or more abnormal results. Most common abnormalities
were hyperfibrinogenemia (62%) and prolonged serial thromhin time (61%) followed by elevated factor
VIII (45%) and VII (38%) , elevated FDP (36%)
and decreased antithrombin III (28%) levels in
decreasing order of frequency.
2. Patients with distant metastases (53%) more
frequently had elevated FDP level compared to those
without distant metastases (8%).
Patients with elevated FDP level showed much
higher frequency of prolonged prothrombin time,
positive protamine sulfate test and decreased antithrombin
III level compared to those with normal
FDP level.
Majority of the patients with increased FDP level
showed laboratory features of compensated or
overcompensated intravascular coagulation and
fibrinolysis.
3. Patients with hepatoma revealed marked abnormalities
in coagulation tests, and compared to
patients with other types of cancer these patients
showed significantly high frequency of prolonged
prothrombin time as well as decreased factor II,
elevated FDP, prolonged thrombin time, thrombocytopenia
and decreased antithrombin III in addition
to markedly increased factor VIII level; these abnormaIities
were considered to be manifestations of
underlying liver cirrhosis. Hepatoma patients without
underlying liver cirrhosis showed normal or elevated
platelet count, fibrinogen and factor VII, whereas
these were markedly decreased in two thirds of the
control patients with liver cirrhosis.
4. Patients with stomach cancer had significantly
shortened prothrombin time and activated partial
thromboplastin time compared to normal controls.
and these findings along with markedly elevated
fibrinogen, factor VII and VIII suggested hypercoagulability
of blood. However about 30% of the
patients had abnormally shortened euglobulin lysis
time, representing features of increased fibrinolysis
Changes in the E-rosette Formation and PHA Blastogenesis of Lymphocytes in Stored Blood.
Changes in the ability of lymphocytes in stored
bank blood to form E-rosettes and to respond to PHA
were studied together with change of other blood cell
components at intervals during two to three weeks
of storage at 4T in ACD-B and CPD plastic bags.
The results were as follows.
1. There was no significant change in red blood
cell count, hemoglobin and hematocrit during 21 days
of storage.
2. Leucocyte count decreased to 90% of the initial
value after 1 week and then there was no significan t
decrease up to 3 weeks of storage. Viability of lymphocytes
was maintained up to two weeks at 9096
level and that of neutrophil declined rapidly to 1/3
of the initial value after 1 week's storage.
3. Platelet count decreased rather slowly and 60%
of the initial value "vas present after 3 weeks'
storage.
4. E-rosette formation of lymphocytes was relatively
well maintained during the first 3 days and
decreased to 2/3 on day 4, and to less than 1/2
after 10-14 days' stroage.
5. Spontaneous and PHA stimulated lymphocyte
blastogenesis decreased progressively during storage.
but was not completely abolished after 14-17 days'
storage
Association of HLA-A, B antigens with susceptibility to advanced endometriosis in Koreans
BACKGROUND: Endometriosis is defined as the presence of endometrial tissue outside the uterus, causing diverse diseases, including infertility, pelvic pain, dysmenorrhea, and constipation. While there is a growing body of evidence that genetic and immunologic factors play important roles in the pathogenesis of the disease, HLA-A, B antigens have been reported to be associated with the risk of endometriosis in the Japanese population. This study was performed to determine whether the susceptibility to advanced endometriosis is also associated with HLA-A, B antigens in the Korean population, which is the closest ethnic group to Japanese. METHODS: We recruited 50 Korean patients with advanced endometriosis confirmed by surgical and histolological examinations. Distribution of HLA-A and B antigens was compared with that of 200 unrelated ethnically matched individuals. HLA-A and B genotyping was carried out using a PCRsequence specific oligonucleotide hybridization method. RESULTS: An increased frequency of B39 was observed in endometriosis patients compared with control subjects, but the difference was not statistically significant after correcting for multiple comparisons (4.0% patients vs 0.8% controls, OR=5.5, 95% CI=1.21-25.04, P=0.03, P(c)=not significant). No significant differences were found between the patients with endometriosis and the general control group with regards to the distribution of other HLA-A and B antigens. CONCLUSIONS: The findings of the present study suggest that the susceptibility to advanced endometriosis, unlike in the Japanese population, is not associated with HLA-A, B antigens in the Korean population.μΈμ λνκ΅ νμ μ°κ΅¬μ‘°μ±λΉ(2006) 보쑰μ μν κ²μ
- β¦